Drug compound characterization by mass spectrometry imaging in cancer tissue.
about
Imaging mass spectrometry for metabolites: technical progress, multimodal imaging, and biological interactions.Chemical genetics-based development of small molecules targeting hepatitis C virus.Clinical protein science developments for patient monitoring in hospital central laboratories.Integration of Ion Mobility MSE after Fully Automated, Online, High-Resolution Liquid Extraction Surface Analysis Micro-Liquid Chromatography.A Poroelasticity Theory Approach to Study the Mechanisms Leading to Elevated Interstitial Fluid Pressure in Solid Tumours.
P2860
Drug compound characterization by mass spectrometry imaging in cancer tissue.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@ast
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@en
type
label
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@ast
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@en
prefLabel
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@ast
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@en
P2093
P2860
P50
P1476
Drug compound characterization by mass spectrometry imaging in cancer tissue.
@en
P2093
Bo Baldetorp
György Marko-Varga
Ho Jeong Kwon
Johan Malm
Ken-ichi Watanabe
Lena Gustavsson
Szilvia Török
Thomas E Fehniger
Toshihide Nishimura
Yutaka Sugihara
P2860
P2888
P304
P356
10.1007/S12272-015-0627-2
P577
2015-07-23T00:00:00Z